Genetic analyses and expression studies identified a novel mutation (W486C) as a molecular basis of congenital coagulation factor XII deficiency

Keiko Ishii, Shuji Oguchi, Takanori Moriki, Yoko Yatabe, Eiko Takeshita, Mitsuru Murata, Yasuo Ikeda, Kiyoaki Watanabe

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

We analyzed the factor XII (FXII) gene of a patient with congenital FXII deficiency and identified a novel amino acid substitution (W486C) in the catalytic domain. The proband was an asymptomatic 49-year-old Japanese female with abnormal coagulation test, discovered by chance. The FXII activity and antigen level were both under 10%, suggesting a cross-reacting material-negative FXII deficiency. Sequence analysis of the proband's FXII gene revealed a homozygous nucleotide substitution G → C in exon 12, resulting in the amino acid substitution W486C in the catalytic domain. We constructed the mutant FXII cDNA in an expression plasmid vector and transfected it into Chinese hamster ovary cells. The recombinant wild-type FXII antigen was detected in the culture medium by immunoprecipitation assay, but the mutant FXII (W486C) was not observed. On the other hand, both the wild-type FXII and W486C cell lysates contained FXII antigen and FXII mRNA, as estimated by western blotting and quantitative reverse transcriptase-polymerase chain reaction. These findings suggest that the W486C substitution of FXII impairs intracellular processing of the protein and/or transport system.

Original languageEnglish
Pages (from-to)367-373
Number of pages7
JournalBlood Coagulation and Fibrinolysis
Volume15
Issue number5
DOIs
Publication statusPublished - 2004 Jul

Fingerprint

Factor XII Deficiency
Factor XII
Mutation
Amino Acid Substitution
Antigens
Catalytic Domain
Protein Transport
Cricetulus
Reverse Transcriptase Polymerase Chain Reaction
Immunoprecipitation
Genes
Sequence Analysis
Culture Media
Ovary
Exons

Keywords

  • Blood coagulation
  • Deficiency
  • Expression study
  • Factor XII
  • Genetics
  • Mutation

ASJC Scopus subject areas

  • Hematology

Cite this

Genetic analyses and expression studies identified a novel mutation (W486C) as a molecular basis of congenital coagulation factor XII deficiency. / Ishii, Keiko; Oguchi, Shuji; Moriki, Takanori; Yatabe, Yoko; Takeshita, Eiko; Murata, Mitsuru; Ikeda, Yasuo; Watanabe, Kiyoaki.

In: Blood Coagulation and Fibrinolysis, Vol. 15, No. 5, 07.2004, p. 367-373.

Research output: Contribution to journalArticle

Ishii, Keiko ; Oguchi, Shuji ; Moriki, Takanori ; Yatabe, Yoko ; Takeshita, Eiko ; Murata, Mitsuru ; Ikeda, Yasuo ; Watanabe, Kiyoaki. / Genetic analyses and expression studies identified a novel mutation (W486C) as a molecular basis of congenital coagulation factor XII deficiency. In: Blood Coagulation and Fibrinolysis. 2004 ; Vol. 15, No. 5. pp. 367-373.
@article{7dd434b7abc54259b83f4ff6f2599b51,
title = "Genetic analyses and expression studies identified a novel mutation (W486C) as a molecular basis of congenital coagulation factor XII deficiency",
abstract = "We analyzed the factor XII (FXII) gene of a patient with congenital FXII deficiency and identified a novel amino acid substitution (W486C) in the catalytic domain. The proband was an asymptomatic 49-year-old Japanese female with abnormal coagulation test, discovered by chance. The FXII activity and antigen level were both under 10{\%}, suggesting a cross-reacting material-negative FXII deficiency. Sequence analysis of the proband's FXII gene revealed a homozygous nucleotide substitution G → C in exon 12, resulting in the amino acid substitution W486C in the catalytic domain. We constructed the mutant FXII cDNA in an expression plasmid vector and transfected it into Chinese hamster ovary cells. The recombinant wild-type FXII antigen was detected in the culture medium by immunoprecipitation assay, but the mutant FXII (W486C) was not observed. On the other hand, both the wild-type FXII and W486C cell lysates contained FXII antigen and FXII mRNA, as estimated by western blotting and quantitative reverse transcriptase-polymerase chain reaction. These findings suggest that the W486C substitution of FXII impairs intracellular processing of the protein and/or transport system.",
keywords = "Blood coagulation, Deficiency, Expression study, Factor XII, Genetics, Mutation",
author = "Keiko Ishii and Shuji Oguchi and Takanori Moriki and Yoko Yatabe and Eiko Takeshita and Mitsuru Murata and Yasuo Ikeda and Kiyoaki Watanabe",
year = "2004",
month = "7",
doi = "10.1097/01.mbc.0000114447.59147.d1",
language = "English",
volume = "15",
pages = "367--373",
journal = "Blood Coagulation and Fibrinolysis",
issn = "0957-5235",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Genetic analyses and expression studies identified a novel mutation (W486C) as a molecular basis of congenital coagulation factor XII deficiency

AU - Ishii, Keiko

AU - Oguchi, Shuji

AU - Moriki, Takanori

AU - Yatabe, Yoko

AU - Takeshita, Eiko

AU - Murata, Mitsuru

AU - Ikeda, Yasuo

AU - Watanabe, Kiyoaki

PY - 2004/7

Y1 - 2004/7

N2 - We analyzed the factor XII (FXII) gene of a patient with congenital FXII deficiency and identified a novel amino acid substitution (W486C) in the catalytic domain. The proband was an asymptomatic 49-year-old Japanese female with abnormal coagulation test, discovered by chance. The FXII activity and antigen level were both under 10%, suggesting a cross-reacting material-negative FXII deficiency. Sequence analysis of the proband's FXII gene revealed a homozygous nucleotide substitution G → C in exon 12, resulting in the amino acid substitution W486C in the catalytic domain. We constructed the mutant FXII cDNA in an expression plasmid vector and transfected it into Chinese hamster ovary cells. The recombinant wild-type FXII antigen was detected in the culture medium by immunoprecipitation assay, but the mutant FXII (W486C) was not observed. On the other hand, both the wild-type FXII and W486C cell lysates contained FXII antigen and FXII mRNA, as estimated by western blotting and quantitative reverse transcriptase-polymerase chain reaction. These findings suggest that the W486C substitution of FXII impairs intracellular processing of the protein and/or transport system.

AB - We analyzed the factor XII (FXII) gene of a patient with congenital FXII deficiency and identified a novel amino acid substitution (W486C) in the catalytic domain. The proband was an asymptomatic 49-year-old Japanese female with abnormal coagulation test, discovered by chance. The FXII activity and antigen level were both under 10%, suggesting a cross-reacting material-negative FXII deficiency. Sequence analysis of the proband's FXII gene revealed a homozygous nucleotide substitution G → C in exon 12, resulting in the amino acid substitution W486C in the catalytic domain. We constructed the mutant FXII cDNA in an expression plasmid vector and transfected it into Chinese hamster ovary cells. The recombinant wild-type FXII antigen was detected in the culture medium by immunoprecipitation assay, but the mutant FXII (W486C) was not observed. On the other hand, both the wild-type FXII and W486C cell lysates contained FXII antigen and FXII mRNA, as estimated by western blotting and quantitative reverse transcriptase-polymerase chain reaction. These findings suggest that the W486C substitution of FXII impairs intracellular processing of the protein and/or transport system.

KW - Blood coagulation

KW - Deficiency

KW - Expression study

KW - Factor XII

KW - Genetics

KW - Mutation

UR - http://www.scopus.com/inward/record.url?scp=3142630194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142630194&partnerID=8YFLogxK

U2 - 10.1097/01.mbc.0000114447.59147.d1

DO - 10.1097/01.mbc.0000114447.59147.d1

M3 - Article

C2 - 15205584

AN - SCOPUS:3142630194

VL - 15

SP - 367

EP - 373

JO - Blood Coagulation and Fibrinolysis

JF - Blood Coagulation and Fibrinolysis

SN - 0957-5235

IS - 5

ER -